Rick Chan

Rick Chan has a diverse and extensive work experience in the pharmaceutical industry. Rick is currently the Vice President of Scientific Affairs at LTS Lohmann Therapie-Systeme AG. Prior to this role, they worked as an Independent Consultant at Rick Chan Consulting and held the position of Executive Scientific Officer (Part-time) at LTS - Lohmann Therapy Systems. Rick also served as the Vice President of R&D at LTS - Lohmann Therapy Systems and was responsible for global R&D strategies for oral thin films technology. Before venturing into consulting and LTS, Rick worked at GlaxoSmithKline in various roles, including Director of New Product Development & Open Innovation at the Venture Group R&D division and Director of New Product Research for Smoking Control at GlaxoSmithKline Consumer Healthcare. Rick has a strong background in research and development, licensing, and strategic partnerships in the pharmaceutical industry.

Rick Chan has a PhD in Pharmaceutical Technology from King's College London. Rick also holds a Graduate Diploma in Business Management from Mt Eliza Business School. Additionally, they have a Master of Science (MSc) in Pharmaceutical Technology, also from King's College London. Prior to these degrees, Rick obtained a Bachelor of Pharmacy (B Pharm) degree from the University of Bradford. Their specialization within pharmacy was in Pharmaceutics. However, no specific start or end years are provided for any of these educational experiences.